ADLM Diagnostics Innovation and COVID Testing
In this Bio Break episode, Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing. The Association for Diagnostics & Laboratory Medicine (ADLM) recently wrapped its annual showcase in Chicago, and as always, it left a strong impression on the medtech community.
While discussing highlights from the show, Nick and Nigel zero in on a perfect case study of ADLM diagnostics innovation: the evolution of COVID-19 testing. From the early days of enzyme-linked immunosorbent assays (ELISAs) to the familiar lateral flow tests we now perform at home, diagnostics have become faster, simpler, and more accessible. This transformation—from complex lab environments to point-of-care and even bathroom-counter diagnostics—was on full display at ADLM.
From the Lab to the Bathroom Counter
As Nick points out, one of the most remarkable shifts in diagnostics is how complicated procedures have been distilled into everyday routines. What once required trained technicians in controlled environments can now be done at home, often with little more than a test strip and a timer. The lateral flow transformation is a clear example of how ADLM’s influence and technology leadership help shape the direction of consumer-friendly diagnostics.
Related Resources
Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.
Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.
Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.
In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.